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1. Introduction 
When it was shown that ganglioside GM1 specific- 
ally bound and inactivated cholera toxin [l] it was of 
interest to study the occurrence of this ganglioside in 
intestinal mucosa, the target organ for the toxin. By 
comparative studies of the small intestinal mucosa in 
man, pig and beef we showed that there was a direct 
relation between the binding ability for cholera toxin 
and the ganglioside GM1 content [2], which suggested 
that ganglioside GM1 is the natural specific receptor 
for cholera toxin. Intestinal mucosa of adult man had 
a remarkably low concentration of ganglioside GM1 , 
and it was of importance both from a theoretical 
point of view, but also for the profylaxis and treat- 
ment of cholera and allied intestinal infectious dis- 
eases [3] to know the actu,al ganglioside GM1 concen- 
tration in intestinal mucosa during development. For 
the determination of the ganglioside concentration 
during the fetal stage we used meconium, which is the 
fist faeces of the newborn and consists mainly of 
extruded mucosal cells from the intestine. The forma- 
tion of meconium starts early during the fetal period, 
and it gives a readily available material for the exami- 
nation of the glycolipid pattern in intestinal mucosa 
during fetal life. The chemical structure of the neutral 
glycolipids has been the subject for a few studies 
[45] and two reports have given thin-layer chromato- 
graphic evidences for the existence of gangliosides 
[S ,6]. To our knowledge this is the first quantitative 
determination and characterization of the ganglio- 
sides in human meconium. 
2. Experimental 
2 .l . Material 
Samples of meconium were collected at the deliv- 
ery ward, Department of Obstetrics and Gynecology, 
&tra sjukhuset, University of Goteborg, and at the 
Obstetric Service, County hospital, Molndal. Silica 
gel 60,230-400 mesh, TLC and HPTLC plates, silica 
gel 60, were obtained from Merck AG, Darmstadt. 
Sephadex G-25 was purchased from Pharmacia Fine 
Chemicals, Uppsala. The anion exchange resin 
Spherosil-DEAE-dextran was a gift from Institute 
MCrieux, Lyon [7]. Vibrio cholerae sialidase (EC 3.2. 
1 .18) wasobtained from Behringwerke AG, Marburgh- 
Lahn. PGalactosidase (EC 3.2.1.32) and P-N-acetyl- 
hexosaminidase isolated from jack beans were gifts 
from Drs S. C. and Y.-T. Li, Tulane University LA. 
2.2. Extraction and isolation of the glycosphin- 
Abbreviations: TLC, thinlayer chromatography; HPTLC, 
high-performance thin-layer chromatography; TMS, trimeth- 
ylsilyl-; GLC-MS, gas-liquid chromatography-mass spec- 
trometry; NeuAc, Nacetylneuraminic acid; gal, galactose; 
glcNAc,N-acetylglucosamine; glc, glucose 
Nomenclature: The gangliosides have been designated accord- 
ing to [ 241. GM3, II”NeuAc-LacCer; GD3, II’(NeuAc),- 
LacCer; GMl, I13NeuAc-GgOse,Cer; GDla, IV”NeuAcII’- 
NeuAc-GgOse,Cer; GTlb, IV3NeuAcI13(NeuAc)z-GgOse,Cer; 
3’-LMl and 6’-LMl, shorthand designation of IV3-nLcOseh 
Cer and IV%LcOse,Cer, respectively 
golipids 
Meconium was pooled from 42 full-term children. 
Only the first portion passed within 24 h from birth, 
was collected and stored at -20°C until extraction. 
The meconium (380 g) was extracted with 20 vol. 
and reextracted with 10 vol. (w/v) of chloroform/ 
methanol/water (4: 8:3, by vol.) [8]. The total lipid 
extract was evaporated to dryness, and dissolved in 
chloroform/methanol/water (60:30:4.5, by vol.). 
Low-molecular contaminants were removed by chro- 
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matography on Sephadex G-25 [9]. The lipid extract 
was applied to a Spherosil-DEAEdextran anion- 
exchange column for the separation of the lipids into 
neutral and acidic lipids. The neutral lipids were eluted 
with chloroform/methanol/water (60:30:4.5, by vol.) 
and the gangliosides with a discontinuous gradient of 
potassium acetate in methanol according to their 
number of sialic acids [7]. The sulphoglycolipids were 
eluted together with the monosialogangliosides. 
The individual gangliosides and sulphoglycolipids 
were isolated by silica column chromatography and 
preparative thin-layer chromatography [8]. The neu- 
tral glycosphingolipids were isolated from an aliquot 
of the neutral lipid fraction by peracetylation and 
chromatography on Florisil [lo]. 
2.3. Analytical methods 
Ganglioside sialic acid was assayed with the resor- 
cinol method [ 111. The distribution of individual 
gangliosides was determined by densitometry as in 
[8]. The total amount of neutral glycosphingolipids 
was determined as sphingosine base with the methyl 
orange method [12]. Monohexosylceramide and 
sulphatide were assayed with the orcinol procedure 
[ 131. The carbohydrate moieties of the glycolipids 
were analysed by GLC as their alditol acetates [14]. 
The fatty acid and sphingosine base composition were 
analysed as in [15]. The 2-hydroxy fatty acids and 
the normal fatty acids were separated as their methyl 
esters by TLC developed in methylene chloride. The 
hydroxy fatty acids were then analysed by GLC as 
their TMS-derivatives. 
2.4. Partial acid and enzymic hydrolyses 
Partial acid hydrolysis of ganghosides was per- 
formed in 1 M formic acid for 30 mm in a boiling 
water bath. Hydrolysis with Vibrio cholerae sialidase 
was performed in 0.01 M Tris-maleate buffer 
(pH 6.5) containing 4 mM CaCl*, with and without 
0.05% (w/v) Triton X-100. The incubations were 
done at 37’C for 16 h. The glycolipid products of the 
hydrolyses were analysed by HPTLC. Degradation 
with exoglycosidases was done as in [ 161. 
2.5. Permethylation studies 
The gangliosides were permethylated, hydrolysed, 
reduced, acetylated and analysed by GC-MS as in 
P71. 
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Table 1 
Concentration of glycosphingofipids (nmol/kg meconium) 
in pooled meconium 
Neutral 
glycolipids 
Acidic glycolipids 
2900 
Sulphoglycohpids 
1400 
Gangliosides 
480 
3. Results 
The concentrations of the different glycosphingo- 
lipid classes in meconium are given in table 1. The 
dominating neutral glycosphingolipid fraction was 
monohexosylceramides, which represented 65 M% of 
them, galactosylceramide constituted 45% and gluco- 
sylceramide 20%. The meconium was also rich in 
complex neutral glycosphingolipids with 4 or more 
sugars (-30% of the total), while di- and triglycosyl- 
ceramides were minor components. 
Sulphoglycolipids dominated among the acidic 
glycolipids, and occurred at 1400pmol/kg meconium, 
galactosylceramide-30-sulphate constituted >95% of 
them. The concentration of gangliosides, expressed as 
pmol NeuAc/kg meconium, was 480 pmol/kg. The 
mono-, di- and polysialogangliosides represented 450, 
20 and 8 I.tmol/kg, respectively. The ganghoside pat- 
tern expressed as percentage sialic acid is given in 
table 2. GM3 was the major ganglioside, and made up 
>80% of the total ganglioside sialic acid. The second 
most abundant ganglioside, 9% of the total, was a 
glucosaminecontaining ganglioside, which had a dif- 
Table 2 
Ganglioside pattern of meconium 
Ganglioside %NeuAc 
Monosialogangliosides 94.0 
GM3 81.3 
3’-LMl 0.8 
6’-LMl 9.0 
GM1 <0.5 
Disialogangiiosides 4.3 
GD3 1.2 
GDla 1.9 
Polysialogangliosides 1.7 
GTlb 1.5 
Volume 133, number 2 FEBS LETTERS 
Table 3 
The relative migration rate (RGMl) by thin-layer chromatography of 3’-LMl 
and 6’-LMI in different solvent systems compared with that of GM1 
Ganglioside Propanol/ Propanol/ Chloroform/ Chloroform/ 
0.25% KC1 water/ methanol/ methanol/ 
(3 :l) (by vol.) ammonia 2.5 M ammonia 0.25% KC1 
(75:25:5) (60:40:9) (60:35:8) 
(by vol.) (by vol.) (by vol.) 
3’-LMl 1.09 1.33 1.47 1 .03 
6’-LMl 0.95 0.88 0.87 0.82 
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ferent thin-layer chromatographic mobility than the 
major glucosaminecontaining ganglioside, 3’-LMl , of 
human tissues (table 3). Several minor monosialogan- 
gliosides were also detected by TLC, but owing to the 
low amount of them, only 3’-LMl (0.8%) and GM1 
(<OS%) were identified. This latter result clearly 
demonstrates that the concentration of ganglioside 
GM1 is very low also during the fetal development. 
Component analyses of the major glucosamine 
containing ganglioside showed it to contain sphin- 
gosine,N-acetylneuraminic acid, glucose, galactose 
andN-acetylglucosamine in the molar ratio 1: 1: 1:2: 1. 
Mild acid hydrolysis, or sialidase treatment with 
detergent added to the incubation buffer, totally 
removed the sialic acid, and gave a neutral tetraglyco- 
sylceramide. Further degradation with /3-galactosidase, 
/3-N-acetylhexosaminidase, and the combined action 
of both, showed the sequence of the sugars to be gal- 
glcNAc-gal-glc-cer. The results of the permethyl- 
ation analyses are given in table 4. The structural 
analyses suggest he following structure of the major 
glucosaminecontaining ganglioside of meconium: 
NeuAca2+6galp 1-+4glcNAcp 1+3galp 1 +klc-cer . 
There was a large difference in the ceramide com- 
position of the two gangliosides,GDla and GTlb, 
belonging to the gangliotetraose series, compared to 
the other glycolipids isolated from meconium. Gangli- 
oside CD1 a and CT1 b had a ceramide composition 
similar to that found in the corresponding gangliosides 
isolated from brain tissue, with high proportion of 
stearic acid, and sphingenine and eicosasphingenine as 
the dominating sphingosine bases. The glucosamine- 
containing ganglioside contained almost only 
2hydroxy fatty acids, with 16:0-22:0 as the domi- 
nating ones, and had a high proportion of phyto- 
sphingosine. A similar ceramide composition was also 
seen in galactosylceramide and in sulphatide. Ganglio- 
side GM3 contained about equal amounts of normal 
and 2hydroxy fatty acids, and had also a high pro- 
portion of phytosphingosines. 
4. Discussion 
In meconium, two gangliosides made up -90% of 
the total ganglioside NeuAc. The major one was GM3, 
which is the common ganglioside in all extraneural 
human tissues, and the other one contained glucos- 
amine. Structural analyses showed this latter ganglio- 
side to be NeuAca2+6-neolactotetraosylceramide 
(6’-LMl). This ganglioside was different from the 
major glucosamine containing ganglioside in other 
Table 4 
Composition of permethylated carbohydrates in the major glucosamme- 
containing ganglioside isolated from meconium, and in the corresponding 
desialylated substance 
2,3,4,6-Me, 
Gal 
2,3,4-Me, 
Gal 
2,4,6-Me, 2,3,6-Me, 
Gal Glc 
3,6-Me, 
GlcNAcNMe 
Ganglioside 0 1 1 1 1 
Desialylated 
substance 1 0 1 1 1 
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human tissues [ 181 by the linkage of the sialic acid to 
the terminal galactose residue, NeuAca2-+6gal instead 
of NeuAccu2+3gal. This has been shown to be a minor 
component in human erythrocyte membranes [19]. 
Chromatographical evidence exists for its presence in 
humanliver and spleen [20], but it has not been found 
in adult human intestinal mucosa [2,21]. 
The NeuAca2-+6gal inkage is hydrolysed much 
slower than the NeuAca2-+3gal inkage by Vibrio 
cholerae sialidase [22], and for the complete degrada- 
tion of 6’-LMl to the corresponding desialylated sub- 
stance, detergent had to be added to the incubation 
mixture. The resistance to the action of sialidase 
could explain the high proportion of this ganglioside 
in meconium, and why the normally dominating 
glucosamine containing ganglioside in human tissues 
(3’-LMl) was only a minor component. Most of the 
gangliosides isolated from meconium (-90%) were 
sialidase labile, which is contradictory to the suspicion 
that the high proportion of NeuAcot2-+6-neolacto- 
tetraosylceramide was caused by degradation of 
sialidase labile gangliosides. Our interpretation of the 
high proportion of NeuAca2+6-neolactotetraosyl- 
ceramide in meconium is that the activity of the 
sialyltransferases are different in the fetuses than in 
adults. This interpretation is supported by the obser- 
vation that acidic oligosacharides isolated from meco- 
nium contained only the NeuAca2+6gal linkage [23]. 
The ganglioside NeuAccw2+6-neolactotetraosylcer- 
amide might then be the first fetal antigen of glyco- 
lipid nature isolated and characterized. 
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